Приказ основних података о документу
Lipid profile as a prognostic factor in cancer patients
dc.creator | Cvetković, Z. | |
dc.creator | Cvetković, B. | |
dc.creator | Petrović, M. | |
dc.creator | Ranić, Marija M. | |
dc.creator | Debeljak-Martačić, Jasmina | |
dc.creator | Vučić, Vesna M. | |
dc.creator | Glibetić, Marija | |
dc.date.accessioned | 2021-04-20T12:16:16Z | |
dc.date.available | 2021-04-20T12:16:16Z | |
dc.date.issued | 2009 | |
dc.identifier.issn | 1107-0625 | |
dc.identifier.uri | http://rimi.imi.bg.ac.rs/handle/123456789/222 | |
dc.description.abstract | Purpose: The relationship between plasma lipid levels and neoplastic diseases is still unclear The aim of this study was to analyse the lipid profile of individuals with non-Hodgkin lymphoma (NHL) or prostate carcinoma (CaP) and to follow serum lipid levels changes in NHL patients according to their response to chemotherapy. Patients and methods: Forty-seven patients with NHL, 57 patients with CaP two control groups composed of 29 and 43 age- and sex-matched healthy adults, related to NHL and CaP patients, respectively, were included in the study. Follow-up studies of NHL patients were carried out after the 3rd and 6th cycle of chemotherapy. Results: Initial plasma cholesterol (Chol), HDL-cholesterol (HDL-Chol) and phospholipids (PL) values were signficantly lower in patients with NHL or CaP than in controls. Following chemotherapy we noticed a progressive increase in lipid levels in NHL patients with complete remission (CR) and stable disease (SD), and further decrease in patients with the disease progression. Conclusion: Decreased plasma Chol, HDL-Chol and PL levels of patients with NHL or CaP can be considered as nonspecific prognostic parameters in patients with these malignancies. | en |
dc.publisher | Balkan Union of Oncology (B.U.ON.) | |
dc.relation | info:eu-repo/grantAgreement/MESTD/MPN2006-2010/145071/RS// | |
dc.rights | restrictedAccess | |
dc.source | Journal of BUON | |
dc.subject | cholesterol | en |
dc.subject | HDL-cholesterol | en |
dc.subject | non-Hodgkin's lymphoma | en |
dc.subject | phospholipids | en |
dc.subject | prognostic factors | en |
dc.subject | prostate cancer | en |
dc.title | Lipid profile as a prognostic factor in cancer patients | en |
dc.type | article | |
dc.rights.license | ARR | |
dc.citation.epage | 506 | |
dc.citation.issue | 3 | |
dc.citation.other | 14(3): 501-506 | |
dc.citation.rank | M23 | |
dc.citation.spage | 501 | |
dc.citation.volume | 14 | |
dc.identifier.pmid | 19810145 | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_rimi_222 | |
dc.identifier.wos | 000270421300021 | |
dc.type.version | publishedVersion |
Документи
Датотеке | Величина | Формат | Преглед |
---|---|---|---|
Уз овај запис нема датотека. |